Nabriva Therapeutics plc

DUBLIN, L2 How do I update this listing?

Nabriva Therapeutics PLC is based out of Dublin. Nabriva Therapeutics AG operates as a clinical stage biopharmaceutical company. The Company focuses on the research and development of novel anti-infective agents to treat serious infections, with a focus on the pleuromutilin class of antibiotics. Nabriva Therapeutics serves communities and hospitals worldwide.Whalewisdom has at least 33 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2018-07-27. The notice included securities offered of Equity

Create Alert

Contact Info

nabriva therapeutics plc
25-28 NORTH WALL QUAY
DUBLIN L2    D01 H104

Business Phone: (610) 816-6640
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2018-07-27 D BIOTECHNOLOGY Equity 26,901,904 21,301,451 5,600,453
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
AXEL BOLTE subscription required
    DIRECTOR
CARRIE BOURDOW subscription required
    DIRECTOR
CHARLES A. ROWLAND subscription required
    DIRECTOR
COLIN BROOM subscription required
    DIRECTOR
DANIEL BURGESS subscription required
    DIRECTOR
FRANCESCO MARIA LAVINO subscription required
    EXECUTIVE OFFICER
GARY SENDER subscription required
    EXECUTIVE OFFICER
GEORGE H. TALBOT subscription required
    DIRECTOR
JENNIFER SCHRANZ subscription required
    EXECUTIVE OFFICER
MARK CORRIGAN subscription required
    DIRECTOR
ROBERT CROTTY subscription required
    EXECUTIVE OFFICER
STEPHEN WEBSTER subscription required
    DIRECTOR
STEVEN GELONE subscription required
    EXECUTIVE OFFICER
THEODORE SCHROEDER subscription required
    EXECUTIVE OFFICER DIRECTOR

Elevate your investments